GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal

GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal

Submitted by admin on February 18, 2022 - 10:37am
Source: 
Fierce Biotech
News Tags: 
GSK
Pfizer
RSV
vaccines
clinical trials
Headline: 
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
snippet: 

GlaxoSmithKline has slammed the brakes on its pivotal maternal respiratory syncytial virus (RSV) vaccine program after a safety assessment, potentially handing an advantage to Pfizer in a close race to market.

Do Not Allow Advertisers to Use My Personal information